Uveitis is a broad term that refers to a large group of eye disorders categorized by intraocular inflammation, a leading cause of visual impairment. Historically, treatment of noninfectious uveitis has depended on corticosteroid drugs. Owing to the myriad of side effects caused by corticosteroids, immunomodulatory therapy has become the preferred treatment for chronic noninfectious intraocular inflammation. Recently, biological response modifiers have established a new era in uveitis therapy, with the range of targets continuing to expand. In this review, we aimed to convey up-to-date information on the treatment of noninfectious uveitis to the general ophthalmologist.
|Translated title of the contribution||Treatment of noninfectious uveitis|
|Number of pages||12|
|Journal||Arquivos Brasileiros de Oftalmologia|
|Early online date||18 Aug 2021|
|Publication status||Published - 2021|
- Noninfectious uveitis
- Immunomodulatory therapy